SP/NK1R overexpression has also been documented in several of the previously mentioned inflammatory conditions with a higher risk of cancer predisposition, e.g., during inflammatory bowel disease—singularly, in ulcerative colitis—which has also been associated with an advanced severe clinical stage and a higher risk of colorectal carcinoma development [59,60,61]. Here, TACR1 is linked to cancer.